These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29278991)

  • 1. Managing Nonoperable Intracranial Bleeding Associated With Apixaban: A Series of 2 Cases.
    Faust AC; Tran DM; Lo C; Lai S; Sheperd L; Liu M; Denetclaw T
    J Pharm Pract; 2018 Feb; 31(1):107-111. PubMed ID: 29278991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing Subdural Bleeding Associated With Rivaroxaban: A Series of 3 Cases.
    Faust AC; Woodard S; Koehl JL; Mees W; Steinke D; Denetclaw TH
    J Pharm Pract; 2016 Jun; 29(3):257-62. PubMed ID: 26787638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: Apixaban-Associated Gluteal Artery Extravasation Reversed With PCC3 Without FFP.
    Denetclaw TH; Tam J; Arias V; Kim R; Martin C
    J Pharm Pract; 2016 Aug; 29(4):427-30. PubMed ID: 26519251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency neurosurgical care in patients treated with apixaban: report of 2 cases.
    Beynon C; Potzy A; Unterberg AW; Sakowitz OW
    Am J Emerg Med; 2015 Jun; 33(6):858.e5-7. PubMed ID: 25572645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products.
    Castillo R; Chan A; Atallah S; Derry K; Baje M; Zimmermann LL; Martin R; Groysman L; Stern-Nezer S; Minokadeh A; Nova A; Huang W; Cang W; Schomer K
    J Thromb Thrombolysis; 2021 Jan; 51(1):151-158. PubMed ID: 32500220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
    Held C; Hylek EM; Alexander JH; Hanna M; Lopes RD; Wojdyla DM; Thomas L; Al-Khalidi H; Alings M; Xavier D; Ansell J; Goto S; Ruzyllo W; Rosenqvist M; Verheugt FW; Zhu J; Granger CB; Wallentin L
    Eur Heart J; 2015 May; 36(20):1264-72. PubMed ID: 25499871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study.
    Schulman S; Gross PL; Ritchie B; Nahirniak S; Lin Y; Lieberman L; Carrier M; Crowther MA; Ghosh I; Lazo-Langner A; Zondag M;
    Thromb Haemost; 2018 May; 118(5):842-851. PubMed ID: 29564837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity.
    Rinehart DR; Lockhart NR; Hamilton LA; Langdon JR; Rowe AS
    Crit Care Med; 2015 Jun; 43(6):e203-7. PubMed ID: 25738855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apixaban-induced subdural bleeding: case presentation and literature review.
    Alayad E; Khairy S; Aloraidi A
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29602894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of 4-Factor Prothrombin Complex Concentrate as an Antidote for Intracranial Bleeding in Patients Taking Direct Factor Xa Inhibitors.
    Grandhi R; Newman WC; Zhang X; Harrison G; Moran C; Okonkwo DO; Ducruet AF
    World Neurosurg; 2015 Dec; 84(6):1956-61. PubMed ID: 26341438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of Apixaban and Rivaroxaban Using Activated Prothrombin Complex Concentrates in Patients with Major Bleeding.
    Sheikh-Taha M; Crawley RM
    Am J Cardiovasc Drugs; 2020 Jun; 20(3):295-299. PubMed ID: 31709499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Observational Study of the Factor Xa Inhibitors Rivaroxaban and Apixaban as Reported to Eight Poison Centers.
    Spiller HA; Mowry JB; Aleguas A; Griffith JR; Goetz R; Ryan ML; Bangh S; Klein-Schwartz W; Schaeffer S; Casavant MJ
    Ann Emerg Med; 2016 Feb; 67(2):189-95. PubMed ID: 26298448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.
    Connolly SJ; Milling TJ; Eikelboom JW; Gibson CM; Curnutte JT; Gold A; Bronson MD; Lu G; Conley PB; Verhamme P; Schmidt J; Middeldorp S; Cohen AT; Beyer-Westendorf J; Albaladejo P; Lopez-Sendon J; Goodman S; Leeds J; Wiens BL; Siegal DM; Zotova E; Meeks B; Nakamya J; Lim WT; Crowther M;
    N Engl J Med; 2016 Sep; 375(12):1131-41. PubMed ID: 27573206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series.
    Schultz NH; Lundblad R; Holme PA
    J Med Case Rep; 2018 May; 12(1):138. PubMed ID: 29764497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Bahit MC; Lopes RD; Wojdyla DM; Held C; Hanna M; Vinereanu D; Hylek EM; Verheugt F; Goto S; Alexander JH; Wallentin L; Granger CB
    Heart; 2017 Apr; 103(8):623-628. PubMed ID: 27798052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probable pulmonary embolism with repeat administration of prothrombin complex concentrate in a factor Xa inhibitor patient.
    King GS; Cottingham LG; Hughes RE; Ratliff PD
    J Clin Pharm Ther; 2018 Dec; 43(6):903-905. PubMed ID: 29885249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
    Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
    J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous Hemopericardium in a Patient Receiving Apixaban Therapy: First Case Report.
    Sigawy C; Apter S; Vine J; Grossman E
    Pharmacotherapy; 2015 Jul; 35(7):e115-7. PubMed ID: 26095120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End-Stage Renal Disease Requiring Chronic Hemodialysis.
    Kufel WD; Zayac AS; Lehmann DF; Miller CD
    Pharmacotherapy; 2016 Nov; 36(11):e166-e171. PubMed ID: 27643979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin.
    Brekelmans MP; Scheres LJ; Bleker SM; Hutten BA; Timmermans A; Büller HR; Middeldorp S
    Thromb Haemost; 2017 Apr; 117(4):809-815. PubMed ID: 28180233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.